PSI
RPRX icon

Planning Strategies Inc.’s Royalty Pharma RPRX Stock Holding History

Planning Strategies Inc.’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$841 Buy
+15
New +$781 ﹤0.01% 776

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Planning Strategies Inc.'s RPRX Position: Q2 2026 in Review

Planning Strategies Inc. opened a new position in Royalty Pharma (RPRX) in Q2 2026: 15 shares worth $841. The stake represents ﹤0.01% of the portfolio and ranks #776 among its holdings.

153 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Planning Strategies Inc. held 15 shares of Royalty Pharma worth $841 as of Q2 2026.
  • Royalty Pharma was a new Planning Strategies Inc. position in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Planning Strategies Inc.'s portfolio in Q2 2026, its #776 holding.
  • 153 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Planning Strategies Inc.'s 13F filing for Q2 2026, filed 27 Jul 2026.